Latest news
Al-Ola Abdallah Reviews Long-Term Teclistamab Outcomes in Multiple Myeloma - OncodailyOncodaily · Fri, 07 Aug 2026 18:39:22 GMTTeclistamab/Talquetamab Hits Record Low HR in Multiple Myeloma - CancerNetworkCancerNetwork · Sun, 02 Aug 2026 16:04:35 GMTTeclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89% - AJMCAJMC · Sat, 01 Aug 2026 12:06:54 GMT